Omega Therapeutics, Inc.
OMGAQ
$0.0381
-$0.0069-15.33%
OTC PK
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 22.40% | -9.58% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 22.40% | -9.58% | |||
| Cost of Revenue | -0.35% | -39.41% | |||
| Gross Profit | 7.09% | 44.80% | |||
| SG&A Expenses | 3.74% | 26.74% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.70% | -17.96% | |||
| Operating Income | 0.97% | 18.93% | |||
| Income Before Tax | -0.85% | 19.00% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -0.85% | 19.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.85% | 19.00% | |||
| EBIT | 0.97% | 18.93% | |||
| EBITDA | 0.95% | 19.34% | |||
| EPS Basic | -0.85% | 19.01% | |||
| Normalized Basic EPS | -0.81% | 18.98% | |||
| EPS Diluted | 0.63% | 17.81% | |||
| Normalized Diluted EPS | -0.81% | 18.98% | |||
| Average Basic Shares Outstanding | 0.01% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.01% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||